Blockchain and healthcare updates
On rare occasions I use this platform to share the work that I’m doing and today is one of those days!
ConsenSys spun off ConsenSys Health, its team dedicated to healthcare and the life sciences, into an independent entity. I’ve long been a part of the internal Health team at ConsenSys and am excited to spin out with the incredible team we’ve built. At ConsenSys Health we will operate globally and use blockchain technology, along with other novel technologies, to address some of healthcare and the life sciences’ most challenging problems. Two thing that I am particularly excited about, and will focus on, are federated learning and making value-based care easier. If that is of interest to you please get in touch.
The above image is taken from Hashed’s newsletter.
Hashed describes PharmaLedger as a “governance first” consortium as opposed to a “use case first” consortium. I think this is closely aligned to how I’ve described PharmaLedger and other business networks before as “platform first.” As I said before, the challenge that PharmaLedger, or any platform/governance first consortium, will have is in building consensus between their members on what use cases to prioritize. This has proven difficult in the past, and the consortia that are the most developed today have started with a specific use case first.
All consortia have ambitions to become platforms but there are different ideas for how to achieve that. For example, the Synaptic Health Alliance describes its first use case as a “logical starting point,” and highlights how the platform can be used “for other efforts.” Moreover, I imagine that ProCredEx is thinking about other credentialed occupations that they can support to in due time, their name is Professional Credentials Exchange, not Provider Credentials Exchange.
If you haven’t already check out my interview with Dan Fritz, Supply Chain Architect at Novartis and PharmaLedger Industry Project Lead on PharmaLedger.
Wake Forest School of Medicine’s Center for Healthcare Innovation is working with Fluree PBC on a “data integration and review tool” whose goal is to identify clinically important results quicker. As far as I can tell the use of blockchain here is to maintain record of data’s origin and verify its integrity.
Seems like this is just an exploration at this point, but this could add new capabilities to the MediLedger network.
What I’m reading this weekend
JPM’s report is focused on digital currencies or other finance applications of blockchain but it is thoroughly researched and a good read. A key quote:
The groundwork is now in place for more mainstream adoption of blockchain technology at the same time that the foundation is being established for the development of digital currency and fast payments.
Mt. Gox was the first major exchange hack and at time there was some worry that Mt. Gox would bring the whole ecosystem down. Some ~650,000 Bitcoin was stolen and the saga continues today.
A nice introduction to prediction markets and the problems they have. I’ve thought about prediction markets for whether individual clinical trials are successful or not, but as the author warns about, I’m not sure there would be enough liquidity for that to work today.
… the company’s digital products are sending personal details about them to more than 20 other internet-based companies. Google, Facebook, and a marketing company called Braze all receive the names of medications people are researching, along with other details that could let them pinpoint whose phone or laptop is being used.
I have had a hard time figuring what to write about Coronavirus here. I am not an epidemiologist and my epistemic status has been, and remains, one of uncertainty. As such I’m going to refrain from expressing opinions on the topic. I encourage everyone to follow experts on the topic and to wash their hands.
I have found former FDA Commissioner Scott Gottlieb and STAT’s Helen Branswell to be good evidence based resources, along with the CDC and WHO. This dashboard from Acoer is helpful for understanding trends (and the data is on a blockchain!).
If you found this newsletter valuable then you can click the button below to sign up for free.
If you’re an existing reader I would deeply appreciate it if you share this with people who would find it a valuable resource. You can share this piece on LinkedIn here, and there is a button for sharing on Twitter below. You can also “like” this newsletter by clicking the heart just below this, which helps me get visibility on SubStack.
My content is free, but if you would like to support me, you can do so on Patron here.